3D Global Biotech Inc. (TPEX:6808)
48.00
+1.00 (2.13%)
Oct 9, 2025, 2:59 PM CST
3D Global Biotech Revenue
3D Global Biotech had revenue of 102.84M TWD in the half year ending June 30, 2025, with 1,024.22% growth. This brings the company's revenue in the last twelve months to 324.87M, up 489.06% year-over-year. In the year 2024, 3D Global Biotech had annual revenue of 265.69M with 1,187.68% growth.
Revenue (ttm)
324.87M
Revenue Growth
+489.06%
P/S Ratio
11.50
Revenue / Employee
n/a
Employees
43
Market Cap
3.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265.69M | 245.05M | 1,187.68% |
Dec 31, 2023 | 20.63M | 6.99M | 51.24% |
Dec 31, 2022 | 13.64M | 2.57M | 23.19% |
Dec 31, 2021 | 11.08M | -2.19M | -16.48% |
Dec 31, 2020 | 13.26M | -4.92M | -27.05% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |